Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRRA | ARDX | INDV | ||
| Company | Sierra Oncology Inc | Ardelyx Inc | Indivior Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 54.98 | 5.99 | 9.51 | ||
| High | 55.17 | 6.25 | 9.54 | ||
| Low | 54.98 | 5.91 | 9.36 | ||
| Last | 54.99 | 6.13 | 9.48 | ||
| Change | +0.02 | +0.14 | -0.20 | ||
| % Change | +0.04% | +2.34% | -2.07% | ||
| Volume | 862,800 | 3,605,205 | 285,604 | ||
| 20-Day Average Volume | 396,690 | 2,544,740 | 1,005,935 | ||
| Previous Close | 54.97 | 5.99 | 9.68 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.91 | 6.01 | 10.86 | ||
| 20-Day Raw Stochastic | 62.96% | 64.82% | 4.40% | ||
| 20-Day Relative Strength | 77.35% | 52.19% | 31.58% | ||
| Weighted Alpha | +89.10 | +10.27 | -58.33 | ||
| Today's Opinion | 100% Buy | 40% Sell | 100% Sell | ||
| Previous Opinion | 100% Buy | 56% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 64% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 06/23/22 | -2.85% since 09/13/24 | -4.24% since 09/13/24 | ||
| Low | 54.65 on 06/24/22 | 5.84 on 09/18/24 | 9.36 on 09/20/24 | ||
| High | 55.19 on 06/24/22 | 6.37 on 09/16/24 | 9.97 on 09/18/24 | ||
| 1-Month | |||||
| %Chg | +0.38% since 05/27/22 | +0.16% since 08/20/24 | -22.86% since 08/20/24 | ||
| Low | 54.58 on 05/31/22 | 5.49 on 09/04/24 | 9.33 on 09/11/24 | ||
| High | 55.19 on 06/24/22 | 6.48 on 08/23/24 | 12.74 on 08/27/24 | ||
| 3-Month | |||||
| %Chg | +69.83% since 03/30/22 | +4.07% since 06/20/24 | -41.08% since 06/20/24 | ||
| Low | 30.87 on 03/31/22 | 5.07 on 07/02/24 | 9.14 on 07/09/24 | ||
| High | 55.19 on 06/24/22 | 8.06 on 07/01/24 | 16.98 on 06/21/24 | ||
| 6-Month | |||||
| %Chg | +144.40% since 12/30/21 | -21.41% since 03/20/24 | -54.94% since 03/20/24 | ||
| Low | 14.91 on 01/24/22 | 5.07 on 07/02/24 | 9.14 on 07/09/24 | ||
| High | 55.19 on 06/24/22 | 9.33 on 05/07/24 | 22.53 on 04/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,342,801 | 1,393,873 | 1,334,669 | ||
| Shares Outstanding, K | 24,419 | 232,700 | 137,879 | ||
| Annual Sales | 0 | 124,460,000 | 1,093,000,000 | ||
| Annual Net Income | -94,660,000 | -66,070,000 | 2,000,000 | ||
| Last Quarter Sales | 0 | 73,220,000 | 299,000,000 | ||
| Last Quarter Net Income | -27,930,000 | -16,450,000 | -107,000,000 | ||
| 60-Month Beta | 0.01 | 0.90 | 0.68 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.33 on 05/06/22 | -0.07 on 08/01/24 | 0.44 on 07/25/24 | ||
| Latest Earnings Date | 08/04/22 | 10/29/24 | 07/25/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.18 | ||